Fresenius Medical Care launches 6008 CAREsystem – Fresenius Medical Care

Fresenius Medical Care launches 6008 CAREsystem - Fresenius Medical Care
April 12, 2021 0 Comments

Press Launch


Fresenius Medical Care, the world’s largest supplier of dialysis services and products, has launched the 6008 CAREsystem for the therapy of sufferers with end-stage renal illness (ESRD). This new dialysis remedy system incorporates Fresenius Medical Care’s highest remedy requirements whereas optimizing dialysis therapy and enhancing financial effectivity. Most significantly, it minimizes the variety of risk-related dealing with steps and reduces complexity in remedy supply.

The 6008 CAREsystem was launched to specialists on the European Dialysis and Transplantation Affiliation / European Renal Affiliation (EDTA/ERA) convention in Vienna, which ended yesterday.

Dominik Wehner, Fresenius Medical Care’s Chief Govt Officer for Europe, Center East and Africa, stated: “The revolutionary 6008 CAREsystem is the subsequent step in our Cardioprotective Hemodialysis idea: It affords a streamlined design to ship superior dialysis remedy extra simply, leaving extra time for direct affected person care. Because of this, extra sufferers can profit from improved outcomes and the next degree of care high quality.”

To allow considerably decreased complexity in remedy supply, Fresenius Medical Care has developed a brand new, all-in-one disposable with utterly pre-connected bloodlines for all therapy modalities.

Dr. Olaf Schermeier, the corporate’s Chief Govt Officer for World Analysis and Growth, said: “Leveraging modern expertise, the brand new 6008 CAREsystem is designed to assist physicians and caregivers. The discount within the variety of risk-related dealing with steps, and within the interactions required in the course of the set-up and disconnection phases, cut back the stress on employees and create an improved expertise for the affected person.” The quite a few improvements constructed into the 6008 CAREsystem mix to create an enhanced dialysis remedy that allows higher total look after sufferers with continual kidney failure. The 6008 CAREsystem additionally reduces the amount and weight of generated waste, making it much more cost-efficient and environmentally pleasant.

The dialyzer (typically described because the “synthetic kidney”) and the dialysis machine are the 2 most vital merchandise in hemodialysis. Whereas the dialyzer filters the affected person’s blood, the dialysis machine pumps it and displays its circulation exterior the physique. The machine additionally maintains the composition of the dialysis resolution and introduces anticoagulants into the blood. Dialysis therapies usually final three to 6 hours, and are often carried out thrice per week.

Greater than half of all dialysis machines used worldwide are made by Fresenius Medical Care.


Notice to the media: Pictures of the brand new 6008 CAREsystem may be discovered beneath.

Fresenius Medical Care is the world’s largest supplier of services and products for people with renal ailments of which about 2.8 million sufferers worldwide frequently bear dialysis therapy. Via its community of three,432 dialysis clinics, Fresenius Medical Care offers dialysis therapies for 294,043 sufferers across the globe. Fresenius Medical Care can be the main supplier of dialysis merchandise reminiscent of dialysis machines or dialyzers. Together with the core enterprise, the corporate focuses on increasing the vary of associated medical providers within the discipline of Care Coordination.


This launch accommodates forward-looking statements which are topic to varied dangers and uncertainties. Precise outcomes might differ materially from these described in these forward-looking statements as a result of sure elements, together with modifications in enterprise, financial and aggressive circumstances, regulatory reforms, overseas alternate fee fluctuations, uncertainties in litigation or investigative proceedings, and the supply of financing. These and different dangers and uncertainties are detailed in Fresenius Medical Care AG & Co. KGaA’s stories filed with the U.S. Securities and Trade Fee. Fresenius Medical Care AG & Co. KGaA doesn’t undertake any duty to replace the forward-looking statements on this launch.



Leave a Reply

Your email address will not be published. Required fields are marked *